GSK’s RSV vaccine for older adults shows positive outcomes in Phase 3 trial
The company’s investigational RSV vaccine candidate RSVPreF3 OA has showed statistically significant and clinically meaningful efficacy in adults…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Jun 22
The company’s investigational RSV vaccine candidate RSVPreF3 OA has showed statistically significant and clinically meaningful efficacy in adults…
31 May 22
Cialis is a PDE-5 inhibitor therapy that can be used to treat erectile dysfunction (ED), the signs and…
19 May 22
The Phase 1 clinical trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for…
12 May 22
The Phase 3 study evaluated the tiragolumab plus Tecentriq in 534 patients with first-line PD-L1-high metastatic non-small cell…
18 Apr 22
In the Phase 2/3 clinical trial in 140 children, a booster dose of Comirnaty has increased neutralizing antibodies…
05 Apr 22
AZD8233 is a novel, investigational ASO therapy designed to reduce blood cholesterol levels in patients with hypercholesterolemia (elevated…
10 Mar 22
The Phase 2/3 EPIC-PEDS study is designed to enrol around 140 paediatric participants, aged below 18 years of…
28 Feb 22
A look at the number of ethical and practical benefits that the direct-to-patient model of clinical trial offers…
We focus on what sponsors should look for when outsourcing to a central lab in China and other…
21 Feb 22
In the interim analysis, Dupixent showed positive results in reducing itch and hives (primary endpoints) but did not…